These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15267120)

  • 1. Fluconazole resistance in Candida albicans: a review of mechanisms.
    Casalinuovo IA; Di Francesco P; Garaci E
    Eur Rev Med Pharmacol Sci; 2004; 8(2):69-77. PubMed ID: 15267120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
    J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida albicans switch phenotypes display differential levels of fitness.
    Vargas K; Srikantha R; Holke A; Sifri T; Morris R; Joly S
    Med Sci Monit; 2004 Jul; 10(7):BR198-206. PubMed ID: 15232493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil.
    Goldman GH; da Silva Ferreira ME; dos Reis Marques E; Savoldi M; Perlin D; Park S; Godoy Martinez PC; Goldman MH; Colombo AL
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):25-32. PubMed ID: 15380275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance.
    MacNeill C; Weisz J; Carey JC
    J Reprod Med; 2003 Feb; 48(2):63-8. PubMed ID: 12621787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
    FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I; Riggle P; Hadley S; Kumamoto CA
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARE-2 fingerprinting of Candida albicans isolates.
    Morschhäuser J; Staib P; Köhler G
    Methods Mol Med; 2005; 118():27-34. PubMed ID: 15888932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
    Siikala E; Rautemaa R; Richardson M; Saxen H; Bowyer P; Sanglard D
    J Antimicrob Chemother; 2010 Dec; 65(12):2505-13. PubMed ID: 20876623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plant oils on Candida albicans.
    Agarwal V; Lal P; Pruthi V
    J Microbiol Immunol Infect; 2010 Oct; 43(5):447-51. PubMed ID: 21075713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump.
    Guo XL; Leng P; Yang Y; Yu LG; Lou HX
    J Appl Microbiol; 2008 Mar; 104(3):831-8. PubMed ID: 18194250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.
    Liu S; Hou Y; Chen X; Gao Y; Li H; Sun S
    Int J Antimicrob Agents; 2014 May; 43(5):395-402. PubMed ID: 24503221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
    Cernicka J; Subik J
    Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal agents can change the balance between resistant and susceptible Candida species].
    Petrini B; Chryssanthou E
    Lakartidningen; 2002 May; 99(20):2293-4. PubMed ID: 12082947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA; Paula CR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.